Items where SHU Author is "Le Maitre, Christine"
|Up a level|
Jump to: Article
Number of items: 16.
PHILLIPS, K. L. E., JORDAN-MAHY, N., NICKLIN, M. J. H. and LE MAITRE, C. L. (2013). Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Annals of the Rheumatic Diseases. (In Press)
DAHLAWI, Haytham, JORDAN-MAHY, Nicola, CLENCH, Malcolm, MCDOUGALL, Gordon J. and LE MAITRE, Christine Lyn (2013). Polyphenols are responsible for the proapoptotic properties of pomegranate juice on leukemia cell lines. Food Science and Nutrition, 1 (2), 196-208.
WANG, Jianru, TIAN, Ye, PHILLIPS, Kate L. E., CHIVERTON, Neil, HADDOCK, Gail, BUNNING, Rowena, CROSS, Alison, SHAPIRO, Irving M., LE MAITRE, Christine and RISBUD, Makarand V. (2013). Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis & rheumatism, 65 (3), 832-842.
ZAINI, Rana G., BRANDT, Kirsten, CLENCH, Malcolm and LE MAITRE, Christine (2012). Effects of bioactive compounds from carrots (Daucus carota L.), polyacetylenes, beta-carotene and lutein on human lymphoid leukaemia cells. Anti-Cancer Agents in Medicinal Chemistry, 12 (6), 640-652.
DUNN, S.L., WILKINSON, J. M., CRAWFORD, A., LE MAITRE, C. and BUNNING, R. A. D. (2012). Cannabinoids: novel therapies for arthritis? Future Medicinal Chemistry, 4 (6), 713-725.
DAHLAWI, H, JORDAN-MAHY, Nikki, CLENCH, Malcolm and LE MAITRE, Christine (2012). Bioactive actions of pomegranate fruit extracts on leukemia cell lines In vitro hold promise for new therapeutic agents for leukemia. Nutrition and Cancer, 64 (1), 100-110.
ZAINI, R, CLENCH, Malcolm and LE MAITRE, Christine (2011). Bioactive chemicals from carrot (Daucus carota) juice extracts for the treatment of leukemia. Journal of Medicinal Food, 14 (11), 1-10.
LE MAITRE, C. L., FRAIN, J., MILLWARD-SADLER, J., FOTHERINGHAM, A. P., FREEMONT, A. J. and HOYLAND, J. A. (2009). Altered integrin mechanotransduction in human nucleus pulposus cells derived from degenerated discs. Arthritis & rheumatism, 60 (2), 460-469.
LE MAITRE, C. L., FOTHERINGHAM, A. P., FREEMONT, A. J. and HOYLAND, J. A. (2009). Development of an in vitro model to test the efficacy of novel therapies for IVD degeneration. Journal of tissue engineering and regenerative medicine, 3 (6), 461-469.
LE MAITRE, C. L., FREEMONT, A. J. and HOYLAND, J. A. (2009). Expression of cartilage-derived morphogenetic protein in human intervertebral discs and its effect on matrix synthesis in degenerate human nucleus pulposus cells. Arthritis research & therapy, 11 (5), R137.
POCKERT, A. J., RICHARDSON, S. M., LE MAITRE, C. L., LYON, M., DEAKIN, J. A., FREEMONT, A. J. and HOYLAND, J. A. (2009). Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis & rheumatism, 60 (2), 482-491.
LE MAITRE, C. L., BAIRD, P., FREEMONT, A. J. and HOYLAND, J. A. (2009). An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. Arthritis research & therapy, 11 (1), R20.
HEATHFIELD, S. K., LE MAITRE, C. L. and HOYLAND, J. A. (2008). Caveolin-1 expression and stress-induced premature senescence in human intervertebral disc degeneration. Arthritis research & therapy, 10 (4), R87.
ALI, R., LE MAITRE, C., RICHARDSON, S., HOYLAND, J. and FREEMONT, A. (2008). Connective tissue growth factor expression in human intervertebral disc: implications for angiogenesis in intervertebral disc degeneration. Biotechnic & Histochemistry, 83 (5), 239-245.
LE MAITRE, C. L., FRAIN, J., FOTHERINGHAM, A. P., FREEMONT, A. J. and HOYLAND, J. A. (2008). Human cells derived from degenerate intervertebral discs respond differently to those derived from non-degenerate intervertebral discs following application of dynamic hydrostatic pressure. Biorheology, 45 (5), 563-575.
HOYLAND, J. A., LE MAITRE, C. and FREEMONT, A. J. (2008). Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology, 47 (6), 809-814.